Skip to main content
Premium Trial:

Request an Annual Quote

GeneDx to Launch Clinical Exome Sequencing Test in Early 2012

Premium

GeneDx is planning an early 2012 launch for XomeDx, a clinical exome sequencing test, the Bio-Reference Laboratories subsidiary said this week.

The test, expected to be available starting in January, is aimed at patients with genetic diseases where more targeted genetic tests were unable to provide a molecular diagnosis.

The Gaithersburg, Md.-based company will run the test in its CLIA-certified laboratory and will apply its clinical expertise, technology, and analysis of family data to identify the genetic defect. It will generate test reports that "will be simple to understand for the clinician, patient, and their family."

The test would join a similar offering from Ambry Genetics, which last week launched its Clinical Diagnostic Exome test for patients with undiagnosed or difficult-to-diagnose genetic disorders (CSN 10/5/2011).

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.